Literature DB >> 26134842

Hepatitis D Virus: Introduction and Epidemiology.

Mario Rizzetto1.   

Abstract

Hepatitis D is caused by the hepatitis D virus (HDV), a unique RNA pathogen that requires the hepatitis B surface antigen (HBsAg) to infect. Hepatitis D is transmitted by the parenteral route. The main susceptible group is patients with chronic HBsAg infection who become superinfected with the virus. Hepatitis D occurs throughout the globe, but control of hepatitis B virus (HBV) in the last two decades has consistently diminished the circulation of HDV in industrialized countries. However, hepatitis D remains a medical issue for injecting drug users (IDUs), as well as immigrants from endemic HDV areas, who are reintroducing the infection in Europe.
Copyright © 2015 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26134842      PMCID: PMC4484953          DOI: 10.1101/cshperspect.a021576

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  58 in total

1.  High prevalence and predominance of hepatitis delta virus genotype 1 infection in Cameroon.

Authors:  Yacouba Foupouapouognigni; Dominique Noah Noah; Michèle Tagni Sartre; Richard Njouom
Journal:  J Clin Microbiol       Date:  2011-01-05       Impact factor: 5.948

2.  Frequency of hepatitis C and D super infection in patients with hepatitis B related complex liver disorders.

Authors:  Saeeda Baig; Anwar Ali Siddiqui; Waqar Uddin Ahmed; Huma Qureshi; Ambreen Arif
Journal:  J Coll Physicians Surg Pak       Date:  2009-11       Impact factor: 0.711

3.  Hepatitis delta in Switzerland: a silent epidemic.

Authors:  Daniel Genné; Isabelle Rossi
Journal:  Swiss Med Wkly       Date:  2011-03-18       Impact factor: 2.193

Review 4.  Epidemiology of hepatitis D.

Authors:  Mario Rizzetto; Alessia Ciancio
Journal:  Semin Liver Dis       Date:  2012-08-29       Impact factor: 6.115

Review 5.  Hepatitis delta: the rediscovery.

Authors:  Mario Rizzetto; Seyed Moayed Alavian
Journal:  Clin Liver Dis       Date:  2013-07-03       Impact factor: 6.126

6.  Prevalence, correlates, and viral dynamics of hepatitis delta among injection drug users.

Authors:  Lauren M Kucirka; Homayoon Farzadegan; Jordan J Feld; Shruti H Mehta; Mark Winters; Jeffrey S Glenn; Gregory D Kirk; Dorry L Segev; Kenrad E Nelson; Morgan Marks; Theo Heller; Elizabeth T Golub
Journal:  J Infect Dis       Date:  2010-09-15       Impact factor: 5.226

7.  Hepatitis delta virus infection among the tribes of the Andaman and Nicobar Islands, India.

Authors:  M V Murhekar; K M Murhekar; V A Arankalle; S C Sehgal
Journal:  Trans R Soc Trop Med Hyg       Date:  2005-07       Impact factor: 2.184

8.  Hepatitis D virus infection in Thailand: HDV genotyping by RT-PCR, RFLP and direct sequencing.

Authors:  A Theamboonlers; T Hansurabhanon; V Verachai; V Chongsrisawat; Y Poovorawan
Journal:  Infection       Date:  2002-06       Impact factor: 3.553

9.  Epidemiological and clinical evaluation of hepatitis B, hepatitis C, and delta hepatitis viruses in Tajikistan.

Authors:  Anis Khan; Fuat Kurbanov; Yasuhito Tanaka; Abeer Elkady; Masaya Sugiyama; Abdusamad Dustov; Masashi Mizokami
Journal:  J Med Virol       Date:  2008-02       Impact factor: 2.327

10.  Eighth major clade for hepatitis delta virus.

Authors:  Frédéric Le Gal; Elyanne Gault; Marie-Pierre Ripault; Jeanne Serpaggi; Jean-Claude Trinchet; Emmanuel Gordien; Paul Dény
Journal:  Emerg Infect Dis       Date:  2006-09       Impact factor: 6.883

View more
  29 in total

Review 1.  Epidemiology, Natural History, and Treatment of Hepatitis Delta Virus Infection in HIV/Hepatitis B Virus Coinfection.

Authors:  Nicole D Ferrante; Vincent Lo Re
Journal:  Curr HIV/AIDS Rep       Date:  2020-08       Impact factor: 5.071

Review 2.  Viral hepatitis: past and future of HBV and HDV.

Authors:  Emmanuel Thomas; Masato Yoneda; Eugene R Schiff
Journal:  Cold Spring Harb Perspect Med       Date:  2015-02-02       Impact factor: 6.915

3.  Amino Acid Substitutions within HLA-B*27-Restricted T Cell Epitopes Prevent Recognition by Hepatitis Delta Virus-Specific CD8+ T Cells.

Authors:  Hadi Karimzadeh; Muthamia M Kiraithe; Anna D Kosinska; Manuel Glaser; Melanie Fiedler; Valerie Oberhardt; Elahe Salimi Alizei; Maike Hofmann; Juk Yee Mok; Melanie Nguyen; Wim J E van Esch; Bettina Budeus; Jan Grabowski; Maria Homs; Antonella Olivero; Hossein Keyvani; Francisco Rodríguez-Frías; David Tabernero; Maria Buti; Andreas Heinold; Seyed Moayed Alavian; Tanja Bauer; Julian Schulze Zur Wiesch; Bijan Raziorrouh; Daniel Hoffmann; Antonina Smedile; Mario Rizzetto; Heiner Wedemeyer; Jörg Timm; Iris Antes; Christoph Neumann-Haefelin; Ulrike Protzer; Michael Roggendorf
Journal:  J Virol       Date:  2018-06-13       Impact factor: 5.103

4.  Hepatitis D infection: from initial discovery to current investigational therapies.

Authors:  Ben L Da; Theo Heller; Christopher Koh
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-23

5.  Nucleic Acid Polymers Are Active against Hepatitis Delta Virus Infection In Vitro.

Authors:  Frauke Beilstein; Matthieu Blanchet; Andrew Vaillant; Camille Sureau
Journal:  J Virol       Date:  2018-01-30       Impact factor: 5.103

6.  The burden and epidemiology of hepatitis B and hepatitis D in Georgia: findings from the national seroprevalence survey.

Authors:  A Kasradze; S Shadaker; T Kuchuloria; A Gamkrelidze; M Nasrullah; L Gvinjilia; D Baliashvili; N Chitadze; M Kodani; A Tejada-Strop; J Drobeniuc; L Hagan; J Morgan; P Imnadze; F Averhoff
Journal:  Public Health       Date:  2020-07-29       Impact factor: 2.427

Review 7.  The evolution and clinical impact of hepatitis B virus genome diversity.

Authors:  Peter A Revill; Thomas Tu; Hans J Netter; Lilly K W Yuen; Stephen A Locarnini; Margaret Littlejohn
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2020-05-28       Impact factor: 46.802

Review 8.  Hepatitis B Virus and Hepatitis D Virus Entry, Species Specificity, and Tissue Tropism.

Authors:  Koichi Watashi; Takaji Wakita
Journal:  Cold Spring Harb Perspect Med       Date:  2015-08-03       Impact factor: 6.915

9.  Current and Future Management of Chronic Hepatitis D.

Authors:  Patrizia Farci; Grazia Anna Niro
Journal:  Gastroenterol Hepatol (N Y)       Date:  2018-06

Review 10.  Viral hepatitis vaccination during pregnancy.

Authors:  Yueyuan Zhao; Hui Jin; Xuefeng Zhang; Bei Wang; Pei Liu
Journal:  Hum Vaccin Immunother       Date:  2016-04-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.